Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1657
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17616234 | AUTOMATED BIOMASS-BASED PERFUSION CONTROL IN THE MANUFACTURING OF BIOLOGICS | Non-Final OA | AMGEN INC. |
| 17294726 | METHODS AND MATERIALS FOR REDUCING AGE-RELATED STRIATED MUSCLE AND COGNITIVE DECLINE | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18239938 | PRIMARY CULTURE METHOD | Non-Final OA | Japanese Foundation For Cancer Research |
| 17693457 | Methods And Compositions For Aesthetic And Cosmetic Treatment And Stimulating Hair Growth | Final Rejection | Pluri Biotech Ltd. |
| 17040993 | METHODS FOR EXPANDING ADHERENT STROMAL CELLS AND CELLS OBTAINED THEREBY | Final Rejection | Pluri Biotech Ltd. |
| 18805940 | COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC T CELL EXPANSION | Final Rejection | MARKER THERAPEUTICS INC. |
| 18057421 | CELL CULTURE MEDIUM | Final Rejection | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | Non-Final OA | The Children's Medical Center Corporation |
| 18477799 | Laminin Culture Protocol | Non-Final OA | Rinri Therapeutics Limited |
| 18281033 | GROWTH FACTORS FOR LABORATORY GROWN MEAT AND OTHER APPLICATIONS | Non-Final OA | Terasaki Institute for Biomedical Innovation |
| 18180377 | METHODS FOR OBTAINING MUSCLE DERIVED CELLS | Non-Final OA | INNOVACELL AG |
| 18070908 | Compositions Derived from Placenta and Methods of Producing the Same | Non-Final OA | StimLabs LLC |
| 17858146 | Compositions Derived from Placenta and Methods of Producing the Same | Final Rejection | StimLabs LLC |
| 17859466 | METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN | Final Rejection | ALTEOGEN, INC. |
| 17835243 | EXTRACELLULAR MATRICES WHICH CAN BE USED AS SCAFFOLD FOR LIVING CELLS | Final Rejection | MAPTECH Holdings UG |
| 16620326 | EX VIVO MEAT PRODUCTION | Final Rejection | WILD TYPE, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy